Vaxil Announces Change of Auditor

Provided By Globe Newswire

Last update: Nov 12, 2021

Not for distribution by US newswire or in United States

NESS-ZIONA, Israel , Nov. 12, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech company announces that the board of directors of the Corporation has appointed Zeifmans LLP as the Corporation’s new auditor, replacing MNP LLP. Vaxil has filed a Notice of Change of Auditor in respect of this change under its profile on SEDAR at www.sedar.com.